-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QSfLVcrefI8spNUmva6Fo/HxvntxoBP1jH1gsYfIttGk+PPKwYs/G6sm0CrlAkbT 0eV6VfFQrg9Tf9/NYu8aJw== 0001042910-99-000372.txt : 19990407 0001042910-99-000372.hdr.sgml : 19990407 ACCESSION NUMBER: 0001042910-99-000372 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 19990406 ITEM INFORMATION: ITEM INFORMATION: FILED AS OF DATE: 19990406 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BMJ MEDICAL MANAGEMENT INC CENTRAL INDEX KEY: 0001036296 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 650676079 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 333-35759 FILM NUMBER: 99588255 BUSINESS ADDRESS: STREET 1: 4800 N FEDERAL HWY STREET 2: SUITE 104 D CITY: BOCA RATON STATE: FL ZIP: 33431 BUSINESS PHONE: 5613911311 MAIL ADDRESS: STREET 1: 4800 N FEDERAL HWY STREET 2: SUITE 104 D CITY: BOCA RATON STATE: FL ZIP: 33431 8-K 1 CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 6, 1999 BMJ Medical Management, Inc. ---------------------------- (Exact Name of Registrant as Specified in Charter) Delaware 001-13785 65-0676079 . -------- --------- ---------- - (State or Other Jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 4800 North Federal Highway, Suite 101E, Boca Raton, Florida 33431 - ----------------------------------------------------------- ----- (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code (561) 391-1311 Item 4. Change in Registrant's Certifying Accountant. On March 30, 1999, Ernst & Young LLP resigned as the independent auditor of BMJ Medical Management, Inc. (the "Company") and its subsidiaries, effective as of that date. Ernst and Young LLP's reports on the financial statements for each of the last two years did not contain any adverse opinion or disclaimer of opinion, and were neither qualified or modified as to uncertainty, audit scope or accounting principles. During the last two fiscal years and subsequent interim period to the date hereof, there have been no disagreements between the Company and Ernst & Young LLP on any matters of accounting principles or practices, financial statement disclosure or auditing scope or procedures which, if not resolved to the satisfaction of Ernst & Young LLP, would have caused it to make reference to the matter in the auditor's report. In connection with the filing of this Form 8-K, Ernst & Young LLP was provided with a copy of this disclosure and was requested by the Company to furnish to the Company a letter addressed to the Commission stating whether Ernst & Young LLP agrees with the above statements. A copy of Ernst & Young LLP's letter to the Commission is attached hereto as Exhibit 16 to this Form 8-K. Item 7. Financial Statements and Exhibits. (c) Exhibits 16 Letter dated April 6, 1999, delivered by Ernst & Young LLP to the Securities and Exchange Commission. 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BMJ Medical Management, Inc. Dated: April 6, 1999 By: /s/ DAVID H.FATER ----------------- David H. Fater Executive Vice-President and Chief Financial Officer 3 EX-16 2 LETTER FROM ERNST & YOUNG LLP April 6, 1999 Securities and Exchange Commission 450 Fifth Street, N.W. Washington, DC 20549 Gentlemen: We have read Item 4 of Form 8-K dated April 6, 1999, of BMJ Medical Management, Inc. and are in agreement with the statements contained in the first, second and third paragraphs on page 2 therein. We have no basis to agree or disagree with other statements of the registrant contained therein. Very truly yours, /s/ Ernst & Young -----END PRIVACY-ENHANCED MESSAGE-----